*Emergent BioSolutions [EBS] received a $400 million contract from the Department of Health and Human Services (HHS) to provide 18.75 million doses of the anthrax vaccine BioThrax through Sept. 2010 for the strategic national stockpile. Contract terms also include an additional $34 million if the Food and Drug Administration approves the company's pending supplement to its biologics license application to extend the shelf life of BioThrax from three years to four years. On top of all that, HHS will provide…
Recommended
Trending
Congress Updates
Upgrading Current GPS Ground System “Now a Viable Option,” As GPS OCX Problems Continue, Space Official Says
Upgrades to the GPS ground system–the Architecture Evolution Plan (AEP)–is an option under consideration by the Defense Department’s space acquisition chief, as problems continue in fielding the GPS Next Generation […]
Graham Says GOP To Move Ahead On Second Reconciliation Bill, With Defense Funds As Priority
Senate Budget Committee Chair Lindsey Graham (R-S.C.) said Wednesday, with the White House’s backing, his panel will move “expeditiously” on crafting a second reconciliation bill, citing priorities for defense and […]
Hegseth Acknowledges Potential $200 Billion Iran Supplemental Request, Final Figure ‘Could Move’
Defense Secretary Pete Hegseth on Thursday acknowledged the Pentagon could potentially ask Congress for $200 billion in supplemental funding to support the ongoing operation against Iran and replenish munitions used […]
Counter-Drone Flyaway Kit Used In U.S. In Early Hours Of Iran Strikes, NORTHCOM Head Says
U.S. Northern Command (NORTHCOM) used a counter small unmanned aircraft system (sUAS) flyaway kit (FAK) in the early hours of the strikes against Iran on Feb. 28, according to Air […]